These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26493458)

  • 1. Patients who discontinued statin treatment: a protocol for cohort study using primary care data.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ Open; 2015 Oct; 5(10):e008701. PubMed ID: 26493458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol.
    Finnikin S; Ryan R; Marshall T
    BMJ Open; 2016 Nov; 6(11):e013120. PubMed ID: 27856481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.
    Finnikin S; Ryan R; Marshall T
    Br J Gen Pract; 2017 Dec; 67(665):e881-e887. PubMed ID: 29061715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.
    Herrett E; Williamson E; Beaumont D; Prowse D; Youssouf N; Brack K; Armitage J; Goldacre B; MacDonald T; Staa TV; Roberts I; Shakur-Still H; Smeeth L
    BMJ Open; 2017 Dec; 7(12):e016604. PubMed ID: 29197834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials.
    Zhou Z; Albarqouni L; Breslin M; Curtis AJ; Nelson M
    BMJ Open; 2017 Sep; 7(9):e017587. PubMed ID: 28963307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
    Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
    JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
    van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
    Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
    BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis.
    Fleetcroft R; Schofield P; Ashworth M
    BMC Health Serv Res; 2014 Sep; 14():414. PubMed ID: 25240604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
    Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
    Geleedst-De Vooght M; Maitland-van der Zee AH; Schalekamp T; Mantel-Teeuwisse A; Jansen P
    Drugs Aging; 2010 Jul; 27(7):589-96. PubMed ID: 20583852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence.
    Tudor K; Brooks J; Howick J; Fox R; Aveyard P
    BMJ Open; 2020 Feb; 10(2):e033070. PubMed ID: 32051312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inception and deprescribing of statins in people aged over 80 years: cohort study.
    Gulliford M; Ravindrarajah R; Hamada S; Jackson S; Charlton J
    Age Ageing; 2017 Nov; 46(6):1001-1005. PubMed ID: 29088364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
    Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population: a benefit-harm modelling study.
    Khalili D; Saadati H; Baradaran HR; Hadaegh F; Steyerberg EW; Woodward M; Danaei G
    BMC Cardiovasc Disord; 2024 Oct; 24(1):575. PubMed ID: 39425029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.